Newer ‘Second-Line’ Diabetes Drug May Outperform Older Meds

<p>THURSDAY, Jun 28 (HealthDay News) — A new drug for form 2
diabetes causes significantly reduction <span>weight gain</span> and might lift reduce risks
for <span>hypoglycemia</span> (low blood sugar), <span>heart attack</span> and cadence than standard
medications, a new investigate indicates.</p>
<p>Researchers in Germany remarkable that a new drug, <span>linagliptin</span>
(Tradjenta), is dictated for use in patients that do not transport good with<span>metformin</span>, a many common first-line drug used to provide a disease.</p>
<p>Patients with <span>type 2 diabetes</span> might stop responding to metformin over
time. Others who do not respond to metformin alone are given a second drug
to assistance them say normal blood sugarine levels. The researchers noted
that that drug they should be prescribed is unclear.</p>
<p>The researchers forked out that many patients are...